A personal experience with My Insights

A personal experience with My Insights for the MiniMed™ 770G system
 

Medtronic’s first-of-its-kind program, My Insights, brings you a new email exclusively available to individuals using the MiniMed™ 770G insulin pump and Guardian™ Sensor 3. It’s a monthly Medtronic dashboard that shares insights like you’ve never seen before, with personalized tips based on your data. There’s no better way to celebrate National Diabetes Month than to get more involved in your diabetes management. Gain valuable insights with no additional effort. 

These aren't generic tips--they're diabetes management insights personalized for you. 

Meet Bill. He’s a Medtronic Ambassador who has worn Medtronic technology for over 20 years! Bill took part in the pilot program that we conducted to enroll individuals into My Insights. He provided some great feedback to us along the way and has become a big fan of My Insights!

Bill’s experience with My Insights
 

Q: Bill, what’s your diabetes story?

I’ve had diabetes for 38 years. I was diagnosed at 25 years old, and I am presently 63 years old. I’ve used Medtronic technology, just as MiniMed was being acquired by Medtronic in 2001.

Q: Can you tell our readers more about My Insights?

My Insights is a monthly personalized report. It features your monthly Time in Range percentage, along with your average above and below Time In Range with a comparison from the last month. It’s good to have your actual blood test results which are a one-time picture. But since your BG (blood glucose) varies throughout the day your daily Time in Range is an important way to see your trend but resets every day. Your A1c is a good tool to see your ongoing average, but you normally wait for three months before getting your next A1c results. With My Insights, it’s a perfect time range to see your trends while giving you the opportunity to make adjustments to tweak it.

Q: What types of things are covered in the monthly email?

The monthly email’s first noticeable result is your monthly Time in Range percentage. But it’s so much more. Along with your monthly Time In Range, My Insights also includes how you did compared to the previous month. After getting My Insights reports now on a regular basis, I now also look for Your Latest Achievement which helps motivate me to get to the next level. 

Another thing that I now look forward to is the Your Latest Opportunity info which shows specific and personalized data that tells me what I’ve been doing along with specific reminders that I can use to improve before the next report.

Q: What is your favorite thing about My Insights?

My favorite thing about My Insights was my monthly Time In Range percentage, but now I also look forward to the Try This recommendations so that I can take action and improve my engagement.  

Get actionable insights
 

Q: Have you made any changes to your behavior since you began receiving personalized tips?

I have adopted the suggestions in My Insights report to modify my behavior and take action. Education is a big part in having better control when you have diabetes, My Insights report gives me that personalized education each month to show me my results along with recommendations.

Q: Has anything changed with your diabetes management (before and after My Insights)?

I’m a goal-oriented person. Before My Insights report was available, I would look at my Time in Range on a daily basis, but it resets every day so a win on Monday may be forgotten when I move to Tuesday. Having a monthly report is a perfect time range to see my trend and take action. I’ve developed new and better habits based on the recommendations from My Insights reports.

Q: Have you shared any of your insights with your healthcare team or family members?

Everyone likes a win, especially dealing with diabetes. I show my wife My Insights report each time it comes in and at my last endocrinologist visit I brought My Insight reports.

Q: If someone isn’t enrolled in My Insights, why would you recommend that they sign up?

Having the My Insights report come to your inbox once a month is a helpful way to get real insight on how you’re doing on a monthly basis along with relevant tips based on your data that can help you remember to take actionable steps to improve your results. It’s an easy way to motivate you to have better control based on real information. This is a real differentiator. Seeing your data can help motivate you to take action.   

Thanks for sharing your story with us, Bill! Do you use the MiniMed 770G insulin pump and Guardian Sensor 3 like Bill? If so, sign up to get your own personalized My Insights email each month.   

This relates to one individual’s experience; thoughts and opinions are his own. My Insights emails are currently only available in the United States and requires for consent to be provided via Communication Preferences in Diabetes.shop. Once enrolled, it will take a few weeks to receive your first report. Note that reports rely on both pump and sensor data.

Important Safety Information: MiniMed^™ 770G System with SmartGuard^™ Technology

The MiniMed^™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed^™ 770G System includes SmartGuard^™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. 

The Medtronic MiniMed^™ 770G System consists of the following devices: MiniMed^™ 770G Insulin Pump, the Guardian^™ Link (3) Transmitter, the Guardian^™ Sensor (3), one-press serter, the Accu-Chek^® Guide Link blood glucose meter, and the AccuChek^®Guide Test Strips. The system requires a prescription.

The Guardian^™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian^™ Sensor (3). 

All therapy adjustments should be based on measurements obtained using the Accu-Chek^® Guide Link blood glucose meter and not on values provided by the Guardian^™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek^® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.  

WARNING: Do not use the MiniMed^™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed^™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed^™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library